a sterile culture supernatant on primary lymphoid organs and lymphocyte populations. Transthoracic inoculation of mice or intranasal inoculation of pigs with virulent A. pleuropneumoniae serotypes 1 and 7 induced thymic cortical lymphoid necrosis. These lesions were reproduced in mice by transthoracic injection of a concentrated sterile culture supernatant. The cytotoxic effect of this culture supernatant was also demonstrated in vitro by using a tetrazolium dye reduction assay. Both porcine and murine thymic lymphocytes as well as splenic T lymphocytes were susceptible to the toxin. Porcine convalescent serum, but not preimmune serum, prevented thymic lesions and neutralized the in vitro cytotoxic effect of the culture supernatant on murine thymic lymphocytes. Thymic lesions also were reproduced in mice by using purified lipopolysaccharide (LPS) from Escherichia coli O111:B4; however, LPS had no in vitro cytotoxic effect on either porcine or murine thymic lymphocytes. These results suggest that secreted A. pleuropneumoniae toxin(s) is capable of affecting host T-lymphocyte populations and may affect host immune function.
Actinobacillus pleuropneumoniae is the etiologic agent of porcine pleuropneumonia, a disease which costs pork producers millions of dollars each year from death of animals, reduced feed efficiency, prophylactic medication, and vaccination costs (13) . The disease is characterized by lesions which include severe necrohemorrhagic pneumonia, pleuritis, and suppurative lymphadenitis. Animals which survive acute infections often become chronic carriers, having poor growth characteristics and increased susceptibility to secondary infections (13, 15) . The organism possesses many virulence factors (capsule, lipopolysaccharide [LPS] , hemolysins, cytotoxins, and proteases) thought to be important in the pathogenesis of acute disease (1, 5, 6, 9, 14) . A recent report has suggested that vaccination with preparations containing secreted factors, such as hemolysin/cytotoxin, provides enhanced protection from acute disease (4) . Little is known, however, about the role of these virulence factors in the production of chronic disease and the carrier state. Therefore, we investigated the effects of live bacterial infection or sterile culture supernatants from two A. pleuropneumoniae serotype 1 and 7 reference strains on the lymphoid organs and lymphocyte populations of mice and pigs. If the organism or its putative virulence factors could affect the primary and secondary lymphoid organs as well as lymphocyte populations, then infection by the organism may inhibit the immunologic response of animals and subsequently contribute to chronic disease and the carrier state.
MATERIALS AND METHODS
Bacteria. A. pleuropneumoniae serotype 1 and 7 reference strains were obtained from Brad Fenwick, College of Veterinary Medicine, Kansas State University, Manhattan. Bacteria were grown and maintained as described previously (4) .
To prepare inocula, bacteria were grown overnight in a shaker bath at 37°C in brain heart infusion broth (Difco Laboratories, Detroit, Mich.) containing 0.01% (wt/vol) NAD (Sigma Chemical Co., St. Louis, Mo.). The following morning, 0.5 ml of the culture was added to 50 ml of fresh medium, and the culture was reincubated for an additional 3 h. The bacteria were harvested by centrifugation at 10,000 x g for 15 min and then resuspended in phosphate-buffered saline (PBS; pH 7.4) to an optical density at 600 nm (OD6.) of 0.05 to 0.075 (approximately 4 x 107 CFU/ml). Additional dilutions of this suspension were made in PBS to prepare suspensions for intranasal inoculation of pigs and transthoracic injection of mice.
Animals and inoculation methods. Pigs used in this study were obtained from the University of Nebraska closed specific-pathogen-free herd, which is periodically monitored for the presence of respiratory pathogens and has had no previous clinical history of pleuropneumonia. BALB/c mice were obtained from a University of Nebraska breeding colony. All animals were housed and maintained in isolation facilities in accordance with our institutional animal care and use committee guidelines.
Acute pleuropneumonia was induced in pigs by using pressurized aerosolization through a nasal cannula as described previously (4) . The inoculum consisted of 2 x 106 CFU of serotype 1 or 4 x 106 CFU of serotype 7 organisms suspended in 5 ml of PBS. Mice were injected transthoracically with 0.1 ml of a PBS suspension containing 2 x 107 CFU of serotype 1 or 2 x 107 CFU of serotype 7 organisms per ml. In certain murine experiments, the bacterial inoculum was replaced with 0.1 ml of a 10-fold concentrate from a sterile cytotoxic culture supernatant described below or 0.1 ml of PBS containing 1.0 mg of purified LPS per ml from Escherichia coli O111:B4 (Difco). Mice injected with 0.1 ml of 10-fold-concentrated uninoculated media served as a negative control. All mice and pigs were killed by euthanasia 24 h after inoculation, and tissues were immediately removed and fixed in 10% buffered formalin. Following fixa- tion, tissues were processed and stained with hematoxylin and eosin by routine methods for histologic examination.
Toxin production. Cytotoxin was prepared from the serotype 1 and 7 A. pleuropneumoniae reference strains by a modification of a method described previously (3) . Briefly, bacteria were grown to log phase in the brain heart infusion-NAD medium described above and harvested by centrifugation (10, an additional 1.5 h. Bacteria were then removed from the culture by centrifugation as described above, and the culture supernatant was filter sterilized, divided into aliquots, and frozen at -20°C. For certain experiments, aliquots of the culture supernatants were heated for 30 min at 56°C to determine heat lability of the toxin or concentrated 10-fold in an Amicon stir cell (Diaflo; Amicon Div., Danvers, Mass.), using a 10-kDa retention membrane for use in Western blot (immunoblot) analysis. Other aliquots of the supernatants were concentrated in a stir cell, using a 100-kDa retention membrane. This retentate was reconstituted to its original volume with RPMI medium containing 0.25% BSA (RPMI-BSA SDS-PAGE, Western blot, and autoradiographic analyses. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) as described by Laemmli (11) and immunoblot analysis procedures were performed as reported previously (4). Briefly, 10-fold concentrates of the culture supernatants were electrophoresed for approximately 2.5 h at a constant voltage of 75 V. Gels were stained with Coomassie brilliant blue dye for protein identification. The proteins in duplicate gels were transferred to nitrocellulose of 0.2-,um pore size (Bio-Rad Laboratories, Richmond, Calif.). Successful transfer was determined by staining the nitrocellulose with 0.2% Ponceau S dye (Sigma), and molecular weight standards were marked with a felt-tip marker. The nitrocellulose was blocked overnight at 4°C in 3% fish gelatin (Sigma) and reaWte4 for 1.5 Fig. 1B . These lesions were characterized by moderate multifocal cortical lymphocyte necrosis and dropout, as evidenced by lymphocyte karyorrhexis and pyknosis with loss of cells in the regions of cortical dendrocytes. Pigs surviving acute bacterial infection had evidence of thymic atrophy and a decrease in the normal cortical/ medullary ratio.
Transthoracic inoculation of mice with virulent A. pleuropneumoniae serotypes 1 and 7 induced lesions, including interstitial pneumonia, purulent pleuritis and lymphadenitis, lymphoid necrosis of splenic nodules and periarteriolar lymphatic sheaths, and diffuse acute thymic cortical lymphoid necrosis. The acute thymic lesions could be reproduced in mice following transthoracic injection of a 10-fold concentrate of bacterial culture supernatant (Fig. 1D) or by transthoracic injection of 0.1 mg of purified E. coli G111:B4 LPS (figure not shown). Less severe pyknotic nuclear changes were also observed in splenic lymphoid nodules in mice after injection of concentrated culture supernatants. Transthoracic injection of 10-fold-concentrated uninoculated medium had no pathologic effect on lymphoid tissues.
In vivo passive protection. Mice injected with the concentrated culture supernatant from serotype 1 organisms preincubated with diluted porcine homologous convalescent serum were passively protected from the development of Table 1 . Unconcentrated culture supernatants from serotype 1 and 7 reference strains had a toxic effect on both porcine and murine thymocytes. Warming a thawed aliquot of the serotype 1 supernatant at 56°C for 30 min reduced the toxicity for murine thymocytes by eightfold. Cytotoxic analysis of serotype 1 and 7 culture supernatants filtered through a membrane with a 100,000-molecular-weight retention showed the retentates, but not the filtrates, to have cytotoxic activity for murine thymocytes. Concentrations of purified E. coli LPS capable of inducing acute thymic lesions in vivo were found to have no in vitro cytotoxic effect on either porcine or murine thymocytes (Table 1) . Serotype 1 culture supernatant was found to have 50% cytotoxic end-point titers of 8 and 16 for the respective murine and porcine splenic T-cell preparations, whereas the serotype 7 culture supernatant possessed a 50o cytotoxic end-point titer of 4 for each of the respective splenic T-cell preparations. Serotype 1 culture supernatant biosynthetically labeled with 35S-methionine retained cytotoxic activity.
Endotoxin determination. The culture supernatant concentrates from serotype 1 and 7 reference strains contained 7.8 X 105 and 4.6 x 105 endotoxic units per ml, respectively, or approximately 7.8 x 10-3 and 4.6 x 10-3 mg of relative standard endotoxin per ml.
SDS-PAGE, Western blot, and autoradiographic analyses of toxin preparations. The protein profiles of the 10-fold concentrates from serotype 1 and 7 culture supernatants are shown in Fig. 2 (lanes B and C) . Both culture supernatants contain a 105-kDa protein (arrows) which is absent from the uninoculated medium control. Western blot analysis of the concentrate from serotype 1 toxic culture supernatant blotted with various preimmune, convalescent, and adsorbed convalescent porcine sera is shown in Fig. 3 factors might adversely affect an animal's lymphoid tissue and thus impair its ability to mount an effective immune response. Such impairment could prevent clearance of the organism after infection and contribute to the establishment of chronic disease and the carrier state. Previous results have shown that various serotypes of this organism produce toxins that kill alveolar macrophages, monocytes, and neutrophils (1, 9, 14) . Frey and Nicolet (6) have purified a 105-kDa protein from the serotype 1 reference strain and have demonstrated that it possesses hemolytic activity. Recently, a protein of similar molecular weight from the serotype 1 reference strain has been shown to form pores in phospholipid membrane bilayers (12) .
Our results indicate that live bacterial infection by serotype 1 and 7 reference strains can induce thymic lesions in mice and pigs. Such lesions may contribute to organ atrophy in pigs surviving live bacterial infection. Similar lesions were reproduced in mice by transthoracic injection of 10-fold concentrates of sterile culture supernatants from these reference strains. Thymic lesions could be prevented by preincubation of the concentrated culture supernatants with homologous porcine convalescent serum. Convalescent sera from animals infected with either the serotype 1 or 7 reference strain reacted in immunoblot analysis with a 105-kDa protein in the concentrated culture supernatant from the serotype 1 organism. Adsorption of these sera with A. pleuropneumoniae whole cells of either reference serotype failed to remove reactivity to this protein, suggesting that it is a secreted product.
Unconcentrated culture supernatants from both reference strains were toxic for porcine and murine thymocytes in an in vitro dye reduction assay. This toxicity was heat labile and present in a fraction of the supernatant having a molecular weight of >100,000. These results suggest that a highmolecular-weight product secreted by A. pleuropneumoniae has cytotoxic activity for thymocytes. That convalescent sera neutralized lesions in vivo and reacted to a 105-kDa protein and several high-molecular-weight bands in immunoblot analysis suggests that one or several of these proteins may have a role in cytotoxic activity. In an effort to identify the macromolecules present in the high-molecular-weight fraction with in vitro cytotoxic activity, we biosynthetically labeled the cytotoxic preparation from A. pleuropneumoniae serotype 1 Whether or not the induction of thymic lymphoid necrosis and possible organ atrophy could lead to a generalized immunosuppression is yet to be determined. There is recent evidence, however, that animals removed from conventional herds via a medicated early weaning program and subsequently reared in isolation have larger mean thymic weights and enhanced growth characteristics when compared with animals reared in the conventional herd (7) . These findings suggest possible relevance to the presence of thymic organ atrophy related to the overall health of the animal and its growth potential.
The observation that A. pleuropneumoniae produces a toxin that can affect T lymphocytes also suggests that the organism may induce a localized immunosuppression of mucosal immune responses due to the destruction of local Tcell populations. A. pleuropneumoniae is known to cause severe suppurative and necrotizing lymphadenitis of bronchial and mediastinal lymph nodes. Similar lesions have been observed in porcine tonsillar tissues, and the organism has been isolated from tonsillar crypts long after initial infection (2, 13) . This destruction of secondary lymphoid tissues may provide a mechanism for persistence of the organism at mucosal surfaces and facilitate its spread to susceptible hosts.
